Brief: Poxel To Participate To Mitochondria-Targetted Drug Development Summit
29/04/2021 17:00
April 29 (Reuters) - POXEL SA POXEL.PA :
* POXEL ANNOUNCES ITS PARTICIPATION AT THE
MITOCHONDRIA-TARGETED
DRUG DEVELOPMENT SUMMIT
Source text for Eikon: ID:nBw2GgV0ra
Further company coverage: POXEL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Poxel SA
See all newsFrance's Poxel Q3 revenue rises on higher TWYMEEG royalties
France's Poxel Q2 revenue rises on higher TWYMEEG royalties
France's Poxel Q1 revenue rises 20% on TWYMEEG sales
Brief: Poxel Announces That A Combined General Meeting Will Be Held On December 11, 2025 And The Availability Of The Preparatory Documents
Brief: Poxel Says Cash Runway Estimated Between Mid To End Q2 2025